Martin T. King, MD, PhD

Martin T. King, MD, PhD, unpacks why fewer grade 2 or higher GI events with rectal spacing can mean fewer colonoscopies, less rectal bleeding, and meaningful quality-of-life gains for patients weighing their radiation options.

Martin T. King, MD, PhD, explains why his hypofractionated rectal spacer trial pushed for state-of-the-art radiotherapy in both arms, a design choice built to isolate the spacer's true clinical benefit.